Mitochondria-associated gene expression perturbation predicts clinical outcomes and shows potential for targeted therapy in neuroblastoma

BackgroundMitochondria have long been considered a potential target in cancer therapy because malignant cells are known for their altered energy production. However, there is a lack of comprehensive research on the involvement of mitochondria-associated proteins (MAPs) in neuroblastoma (NB), and the...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Chengwei Chai, Yan Chen, Yuanyuan Luo, Hong Zhang, Zhihua Ye, Xiaobing He, Yan Zou, Yingyi Xu, Le Li, Jue Tang, Qiang Wu
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2023-03-01
Saila:Frontiers in Pediatrics
Gaiak:
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fped.2023.1094926/full